Abstract

To see if having a higher BODE index in chronic obstructive pulmonary disease correlates with having smoked for more years. To see if a higher BODE index is linked to more days spent in the hospital for patients. To see if a higher BODE is linked to more severe cardiac involvement. To see if a greater BODE index is linked to a patient's low nutritional status. To see if BODE index is linked to systemic inflammation. Methods: This study was carried out at Department of Pulmonary Medicine and General Medicine, Government General Hospital Kakinada between August 2021 to February 2022. After obtaining institutional ethics committee approval. The BODE score was evaluated as a predictor of hospitalization and severity of systemic involvement in individuals with Chronic Obstructive Pulmonary Disease using a case control study design with sample size 60 (case: 40; controls: 20). Results: As a result, our study suggests that the BODE index is reliable in determining the hospitalization and severity of systemic involvement in COPD patients and not only an indicator of mortality. The BODE index is extremely useful in evaluating COPD patients in any health-care setting. This will also organize the appropriate referral of COPD cases to the next level, resulting in the use of less resources. Conclusion: The BODE index is a valid tool for determining the severity of COPD. The BODE index is directly connected to the length and intensity of smoking. It predicts hospitalization due to various causes of COPD. Systemic inflammation increases with increase in the severity of COPD. The changes in BMI and serum albumin can be attributed to reduction in nutritional status of COPD patients which is directly correlated by BODE index. An increase in cardiac effects with the severity of disease was seen when it was assessed by BODE index. Severe COPD is associated with Polycythemia

Description